Jomphe V, Lands L, Mailhot G
Nutrients. 2018; 10(6).
PMID: 29921799
PMC: 6024852.
DOI: 10.3390/nu10060790.
Cianferotti L, Cricelli C, Kanis J, Nuti R, Reginster J, Ringe J
Endocrine. 2015; 50(1):12-26.
PMID: 25931412
DOI: 10.1007/s12020-015-0606-x.
Kennedy D, Cooley K, Skidmore B, Fritz H, Campbell T, Seely D
Cancers (Basel). 2013; 5(1):255-80.
PMID: 24216707
PMC: 3730309.
DOI: 10.3390/cancers5010255.
Shroff R, Knott C, Gullett A, Wells D, Marks S, Rees L
Pediatr Nephrol. 2011; 26(12):2227-33.
PMID: 21643944
DOI: 10.1007/s00467-011-1920-z.
Picado C, Luengo M
Drug Saf. 1996; 15(5):347-59.
PMID: 8941496
DOI: 10.2165/00002018-199615050-00005.
Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess.
Seeman E, Kumar R, Hunder G, Scott M, Heath 3rd H, Riggs B
J Clin Invest. 1980; 66(4):664-9.
PMID: 7419714
PMC: 371639.
DOI: 10.1172/JCI109902.
Changes in plasma half-life and clearance of 3H-25-hydroxyvitamin D3 in patients with intestinal malabsorption.
Batchelor A, Watson G, Compston J
Gut. 1982; 23(12):1068-71.
PMID: 7173717
PMC: 1419852.
DOI: 10.1136/gut.23.12.1068.
Protective effect on vitamin D2 on bone apposition from the inhibitory action of hydrocortisone in rats.
Tam C, Wilson D, Hitchman A, Harrison J
Calcif Tissue Int. 1981; 33(2):167-72.
PMID: 6783273
DOI: 10.1007/BF02409430.
Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man.
Hahn T, Halstead L, STRATES B, IMBIMBO B, Baran D
Calcif Tissue Int. 1980; 31(2):109-15.
PMID: 6770974
DOI: 10.1007/BF02407171.
Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans.
Gennari C, IMBIMBO B, Montagnani M, Bernini M, Nardi P, Avioli L
Calcif Tissue Int. 1984; 36(3):245-52.
PMID: 6432287
DOI: 10.1007/BF02405325.
25-Hydroxycholecalciferol as an antagonist of adverse corticosteroid effects on phosphate and calcium metabolism in man.
Nuti R, Vattimo A, Turchetti V, Righi G
J Endocrinol Invest. 1984; 7(5):445-8.
PMID: 6239890
DOI: 10.1007/BF03348448.
Effect of cortisone on vitamin D metabolim in rat plasma.
von Herrath D, Opitz A, Koch H, Knoop H, Schaefer K
Klin Wochenschr. 1971; 49(1):48-9.
PMID: 5545960
DOI: 10.1007/BF01494067.
Recent progress in calcium metabolism: clinical application.
GORDAN G
Calif Med. 1971; 114(5):28-43.
PMID: 4932406
PMC: 1501987.
Effects of 1,25-dihydroxycholecalciferol on intestinal calcium transport in cortisone-treated rats.
Favus M, Walling M, KIMBERG D
J Clin Invest. 1973; 52(7):1680-5.
PMID: 4718960
PMC: 302443.
DOI: 10.1172/JCI107349.
Effects of cortisone administration on the metabolism and localization of 25-hydroxycholecalciferol in the rat.
Favus M, KIMBERG D, Millar G, Gershon E
J Clin Invest. 1973; 52(6):1328-35.
PMID: 4703222
PMC: 302395.
DOI: 10.1172/JCI107304.
Bone disease and chronic renal failure.
Bourke E
Ir J Med Sci. 1974; 0(0):suppl:72-4.
PMID: 4604173
DOI: 10.1007/BF02938129.
The diagnosis and treatment of hyperparathyroidism after renal homotransplantation.
Geis W, Popovtzer M, Corman J, Halgrimson C, Groth C, Starzi T
Surg Gynecol Obstet. 1973; 137(6):997-1010.
PMID: 4586351
PMC: 2744308.
The effect of Prednisolone upon the metabolism and action of 25-hydroxy-and 1,25-dihydroxyvitamin D3.
Carre M, Ayigbede O, MIRAVET L, Rasmussen H
Proc Natl Acad Sci U S A. 1974; 71(8):2996-3000.
PMID: 4528777
PMC: 388606.
DOI: 10.1073/pnas.71.8.2996.
[Calcium absorption in health and disease. II. Syndromes of imparied calcium absorption (author's transl)].
Ewe K
Klin Wochenschr. 1974; 52(2):64-73.
PMID: 4361437
DOI: 10.1007/BF01468328.
Effect of cortisone treatment on the active transport of calcium by the small intestine.
KIMBERG D, BAERG R, Gershon E, Graudusius R
J Clin Invest. 1971; 50(6):1309-21.
PMID: 4325312
PMC: 292062.
DOI: 10.1172/JCI106610.
